Histopathologic effects of tamoxifen on the uterine epithelium of breast cancer patients: Analysis by menopausal status

Cancer Letters

Volumn 101, Issue 1, 1996, Pages 59-66

  McGonigle, Kathryn F ^a   Lantry, Selena A ^a   Odom Maryon, Tamara L ^a   Chai, Akiko ^a   Vasilev, Steven A ^a   Simpson, Jean F ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Polyps; Tamoxifen

Indexed keywords

TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CONTROLLED STUDY; ENDOMETRIUM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENOPAUSE; POLYP; PRIORITY JOURNAL;

EID: 0030046480     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04114-6     Document Type: Article

References (19)

1. Bush, T.L. and Helzlsouer, K.J. (1993) Tamoxifen for the primary prevention of breast cancer: a review and critique of the concept and trial. Epidemiol. Rev., 15, 233-243.
2. Sunderland, M.C. and Osborne, C.K. (1991) Tamoxifen in premenopausal patients with metastatic breast cancer: a review. J. Clin. Oncol., 9, 1283-1297.
3. Lahti, E., Blanco, G., Kauppila, A., Apaja-Sarkkinen, M., Taskinen, P.J. and Laatikainen, T. (1993) Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet. Gynecol., 81, 660-664.
4. Neven, P., De Muylder, X., Van Belle, Y., Vanderick, G. and De Muylder, E. (1989) Tamoxifen and the uterus and endometrium. Lancet, i, 375 (letter).
5. Ford, M.R.W., Turner M.J., Wood, C. and Soutter, W.P. (1988) Endometriosis developing during tamoxifen therapy. Am. J. Obstet. Gynecol., 158, 1119.
6. Dilts, P.V., Hopkins, M.P., Chang, A.E. and Cody, R.L. (1992) Rapid growth of leiomyoma in patient receiving tamoxifen. Am. J. Obstet. Gynecol., 166, 167-168.
7. Cohen, I., Rosen, D.J.D., Altaras, M., Beyth, Y., Shapira, J. and Yigael, D. (1994) Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth. Br. J. Cancer., 69, 620-621 (letter).
8. Fisher, B., Costantino, J.P., Redmond, C.K., Fisher, E.R., Wickerham, D.L., Cronin, W.M. and other NSABP contributors (1994) Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J. Natl. Cancer. Inst., 86, 527-537.
9. Fornander, T., Rutqvist, L.E., Cedermark, B., Glas, U., Mattsson, A., Silfversward, C., Skoog, L., Somell, A., Theve, T., Wilking, N., Askergren, J. and Hjalmar, M. (1989) Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet, i, 117-120.
10. Jordan, V.C. and Assikis, V.J. (1995) Endometrial carcinoma and tamoxifen: clearing up a controversy. Clin. Cancer Res., 1, 467-472.
11. Hosmer, D.W. and Lemeshow, S.L. (1989) Applied Logistic Regression. Wiley, New York.
12. Harris, J.R., Lippman, M.E., Veronesi, U. and Willett, W. (1992) Breast cancer (third of three parts). N. Engl. J. Med., 327, 473-480.
13. Karlsson, B., Granberg, S., Wikland, M., Ryd, W. and Norstrom, A. (1993) Endovaginal scanning of the endometrium compared to cytology and histology in women with postmenopausal bleeding. Gynecol. Oncol., 50, 173-178.
14. Gibson, L.E., Barakat, R.R., Venkatraman, E.S. and Hoskins, W.J. (1996) Endometrial pathology at dilatation and curettage in breast cancer patients: comparison of tamoxifen users and nonusers. Cancer J., in press.
15. Powles T.J., Hickish, T.F., Kanis, J.A. and Ashley, S. (1995) Tamoxifen preserves bone mineral density in postmenopausal women but causes loss of bone density in premenopausal women. Proc. Am. Soc. Clin. Oncol., 14, 165.
16. Pasqualini, J.R., Sumida, C. and Giambiagi, N. (1988) Pharmacodynamic and biological effects of anti-estrogens in different models. J. Steroid Biochem., 31, 613-643.
17. Kurman, R.J. and Mazur, M.T. (1987) Benign diseases of the endometrium. In: Blaustein's Pathology of the Female Genital Tract, pp. 292-321. Editor: R.J. Kurman. Springer-Verlag, New York.
18. LiVolsi, V.A., Salhany, K.E. and Dowdy, Y.G. (1995) Endocervical adenocarcinoma in tamoxifen-treated patient. Am. J. Obstet. Gynecol., 172, 1065 (letter).
19. Silva, E.G., Tornos, C.S. and Follen-Mitchell, M. (1994) Malignant neoplasms of the uterine corpus in patients treated for breast carcinoma: the effects of tamoxifen. Int. J. Gynecol. Pathol., 13, 248-258.